Story · Medicine & Biotech

AstraZeneca Readies New Portfolio of Targeted Cancer Therapies

1 outlet · first reported by WSJ Health 17d ago

Coverage, in order

  1. 17d ago
    WSJ Health mainstream
    AstraZeneca Readies New Portfolio of Targeted Cancer Therapies

    AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to cement its position in one of the fastest-growing corners of the oncology market.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.